Detalhe da pesquisa
1.
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.
Blood
; 143(19): 1891-1902, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295337
2.
Management of ALL in adults: 2024 ELN recommendations from a European expert panel.
Blood
; 143(19): 1903-1930, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306595
3.
Practice guideline: Preparation for CAR T-cell therapy in children and young adults with B-acute lymphoblastic leukaemia.
Br J Haematol
; 204(5): 1687-1696, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38488312
4.
Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.
Blood
; 138(11): 948-958, 2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895809
5.
Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials.
Haematologica
; 107(9): 2051-2063, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788984
6.
Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome-positive relapsed/refractory acute lymphoblastic leukemia.
Cancer
; 127(6): 905-913, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231879
7.
The diagnostic and clinical significance of granulomas in gastrointestinal biopsies from haematopoietic transplant patients.
Histopathology
; 78(5): 772-777, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33217036
8.
BEAM-Campath Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Lymphoma: High Incidence of Long-Term Mixed Donor-Recipient Chimerism and the Response to Donor Lymphocyte Infusions.
Biol Blood Marrow Transplant
; 26(12): 2271-2278, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32890747
9.
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 26(5): 835-844, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31505228
10.
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 26(7): 1247-1256, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32165328
11.
Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.
Biol Blood Marrow Transplant
; 26(2): 333-342, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31563573
12.
The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis.
Biol Blood Marrow Transplant
; 26(9): 1747-1756, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32464284
13.
Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research.
Biol Blood Marrow Transplant
; 26(3): 553-561, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31726205
14.
At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial.
Br J Haematol
; 191(1): 37-43, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32220069
15.
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.
Haematologica
; 105(5): 1329-1338, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558669
16.
Recent Advances in the Management of Acute Lymphoblastic Leukaemia.
Curr Treat Options Oncol
; 21(3): 23, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32095902
17.
Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 25(9): 1720-1729, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31039409
18.
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.
Biol Blood Marrow Transplant
; 25(7): 1424-1431, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871976
19.
Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study.
Biol Blood Marrow Transplant
; 25(3): 443-450, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30935664
20.
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 25(1): 73-85, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30153491